We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




More-Sensitive Rat Microarray for Genome Screening

By Biotechdaily staff writers
Posted on 21 May 2003
A 60-mer oligonucleotide rat microarray kit for genome screening and toxicogenomic research is designed for use in drug discovery and development.

The microarray kit will be used to identify toxic substances and understand how human genes respond and interact in human disease caused by environmental pollutants or toxicants. More...
The kit was developed by Agilent Technologies, Inc. (Palo Alto, CA, USA; www.agilent.com), in collaboration with the US National Institute of Environmental Health Sciences (NIEHS) and Paradigm Genetics (Research Triangle Park, NC, USA).
Agilent said this microarray is 5-10 times more sensitive than regular 25-mer arrays.

Rat genes were selected on the latest content of the public RefSeq database, human and mouse homologues, and proven toxic response genes identified by NIEHS. The kit includes five microarrays, printed on standard glass slides, with more than 20,000 unique rat gene probes per microarray, providing broad genome coverage and specialized content for toxicogenomics researchers.

"We hope these advancements will slash the time and expense of testing chemicals for potential harmful effects, enabling faster and more scientifically based regulatory decision-making,” said Heinrich Gugger, Ph.D., president and CEO of Paradigm Genetics.




Related Links:
Agilent

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Multi-Chamber Washer-Disinfector
WD 390
New
Repetitive Pipette
VWR® Stepper Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.